<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2025.1529215</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>PM<sub>2.5</sub> affected ciliary beat frequency of axonemes via the cyclic AMP-dependent protein kinase a pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Pang</surname> <given-names>Jinyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2901444/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Xiong</surname> <given-names>Zhiqin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Kexin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Yang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2895957/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratory for Clinical Medicine, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Lortta M&#x00FC;ller, University Children&#x2019;s Hospital Bern, Switzerland</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Jian Wu, Guangdong Provincial People&#x2019;s Hospital, China</p>
<p>Adam Speen, University of North Carolina System, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Yang Li, <email>li_yang@ccmu.edu.cn</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1529215</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Pang, Xiong, Zhang and Li.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Pang, Xiong, Zhang and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Long-term inhalation of fine particulate matter (PM<sub>2.5</sub>) has been linked to the onset of various lung diseases. The mucociliary clearance system, acts as the primary host defense mechanism in the airways, with ciliary beat frequency (CBF) being a key parameter for assessing its functionality. The primary aim of this study was to demonstrate the impact of PM<sub>2.5</sub> on CBF and to investigate the potential mechanisms by which PM<sub>2.5</sub> induced changes in CBF through airway axonemes. Airway axonemes were extracted from bovine ciliated epithelium and treated with different concentrations of PM<sub>2.5</sub><italic>in vitro</italic> for 10&#x202F;min and 1&#x202F;h to simulate short-term and prolonged exposures. Additionally, the pathway was examined using PKA activator (cAMP) and PKA inhibitor (PKI) on ciliary axonemes. The results revealed that PM<sub>2.5</sub> stimulated CBF in airway axonemes via the cAMP-PKA pathway. Low concentrations and short-term exposure to PM<sub>2.5</sub> stimulated CBF elevation, however, high concentration and prolonged exposure to PM<sub>2.5</sub> might damage respiratory cilia, thereby increasing the risk of respiratory diseases.</p>
</abstract>
<kwd-group>
<kwd>PM2.5</kwd>
<kwd>ciliary beat frequency</kwd>
<kwd>cAMP</kwd>
<kwd>PKA</kwd>
<kwd>airway axonemes</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="9"/>
<word-count count="6634"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Environmental Health and Exposome</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Evidence indicated that air pollution had already become a significant health threat to global public health at this stage. According to statistics from the World Health Organization, non-communicable diseases caused by environmental and household air pollution, including respiratory diseases, cardiovascular and cerebrovascular diseases, and cancer, resulted in approximately 7 million deaths annually (<xref ref-type="bibr" rid="ref1">1</xref>). Moreover, in the analysis of specific risk factors for the global disease burden in 2021, particulate matter air pollution was the largest contributor to the global burden of diseases, accounting for 8.0% (95% UI 6.7&#x2013;9.4%) of the total disability-adjusted life years (DALYs) (<xref ref-type="bibr" rid="ref2">2</xref>). Statistical data indicated that in China, approximately 350,000 to 500,000 people died annually due to air pollution (<xref ref-type="bibr" rid="ref3">3</xref>). Fine particulate matter (PM<sub>2.5</sub>) is airborne particles with a diameter &#x2264; 2.5&#x202F;&#x03BC;m. It was one of the most complex and most harmful in the air contaminants (<xref ref-type="bibr" rid="ref4">4</xref>). Environmental PM<sub>2.5</sub> is composed of various components, with different components exhibiting varying degrees of toxicity to humans. Moreover, PM<sub>2.5</sub> particles were easily inhaled and deposited in the airways, causing lung injury and exacerbating a range of respiratory diseases, such as chronic obstructive pulmonary disease (<xref ref-type="bibr" rid="ref5">5</xref>), pulmonary fibrosis (<xref ref-type="bibr" rid="ref6">6</xref>), asthma (<xref ref-type="bibr" rid="ref7">7</xref>), and cancer (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>To combat the threat posed by fine particulates, pathogens, and other harmful substances, the body has strategically positioned the mucociliary clearance (MCC) system as the initial line of defense within the respiratory tract. The MCC system is the primary defense mechanism of the respiratory epithelium. The mucus, secreted by goblet cells within the epithelium and submucosal glands, serves as a carrier, capturing and transporting these particles. Cilia propel the mucus and the particles it adsorbs from the bronchi toward the gastrointestinal tract through coordinated beating patterns, thereby clearing inhaled particles, maintaining airway patency, and preventing particles from penetrating deeper into the lungs (<xref ref-type="bibr" rid="ref9">9</xref>). Ciliary beat frequency (CBF) is an important parameter of MCC efficiency (<xref ref-type="bibr" rid="ref10">10</xref>), and CBF has been proved to be an important physiological marker of airway mucosal health (<xref ref-type="bibr" rid="ref11">11</xref>). When ciliary function was impaired, it could lead to upper respiratory tract inflammation, which might be chronic, recurrent, and more severe, resulting in dysfunction of MCC (<xref ref-type="bibr" rid="ref12">12</xref>). CBF was influenced by various factors, in addition to genetic causes of ciliary dyskinesia, including temperature (<xref ref-type="bibr" rid="ref13">13</xref>), pH value (<xref ref-type="bibr" rid="ref14">14</xref>), tobacco (<xref ref-type="bibr" rid="ref15">15</xref>) and alcohol (<xref ref-type="bibr" rid="ref16">16</xref>). Some medications used to treat asthma or other respiratory conditions, such as <italic>&#x03B1;</italic>-sympathomimetic drugs (<xref ref-type="bibr" rid="ref17">17</xref>), carbocysteine (<xref ref-type="bibr" rid="ref18">18</xref>), naringenin (<xref ref-type="bibr" rid="ref19">19</xref>), and long-acting muscarinic antagonists (<xref ref-type="bibr" rid="ref20">20</xref>), have also been shown to affect CBF. In addition, it has been reported that PM<sub>2.5</sub> entering the respiratory tract could cause structural and functional abnormalities in airway cilia, leading to mucus transport failure, which is one of the reasons for the development of respiratory diseases (<xref ref-type="bibr" rid="ref21">21</xref>). However, the role of environmental pollutant PM<sub>2.5</sub> in the beating of airway-ciliated epithelial cell axonemes has rarely been described in studies, and the underlying mechanisms remain unclear.</p>
<p>CBF of the ciliary axonemes is regulated by a variety of intracellular physiological molecules. Cyclic guanosine monophosphate (cGMP), cyclic adenosine monophosphate (cAMP) and Ca<sup>2+</sup> are considered to be important secondary messengers mediating changes in CBF (<xref ref-type="bibr" rid="ref22">22</xref>). The main cellular receptor for the second messenger cAMP is cAMP-dependent protein kinase A (PKA). The cAMP-PKA signaling is one of the common regulatory pathways in mammals. It has been previously demonstrated that ATPase-dependent motility of cilia in bovine bronchial epithelial cells was regulated by cyclic nucleotides, and that cAMP regulated ciliary CBF via PKA (<xref ref-type="bibr" rid="ref23">23</xref>). The cAMP-PKA pathway was considered to play a crucial role in the key functions of MCC and airway defense. Previous studies had demonstrated that the activation or inhibition of the cAMP-PKA pathway could directly influence the development of several respiratory diseases, including asthma, airway fibrosis, chronic obstructive pulmonary disease (COPD), and cancer (<xref ref-type="bibr" rid="ref24 ref25 ref26">24&#x2013;26</xref>). The previous sections have adequately elucidated that the cAMP-PKA signaling pathway in the respiratory tract was essential for the efficient clearance of particulate matter and airway defense. However, it is not yet fully understood whether PM<sub>2.5</sub> can impair ciliary motility by affecting the cAMP-PKA pathway.</p>
<p>The aim of the study was to investigate the effects of PM<sub>2.5</sub> on CBF in respiratory ciliary axonemes and the underlying mechanisms. The study was divided into two parts. In the first part, CBF of airway ciliary axonemes cultured <italic>in vitro</italic> was measured following exposure to different concentrations of PM<sub>2.5</sub> for 10&#x202F;min and 1&#x202F;h, respectively, to observe the impact of varying exposure times and concentrations of PM<sub>2.5</sub> on axoneme motility. In the second part, the axonemes were exposed to different concentrations of PM<sub>2.5</sub> under the influence of cAMP (a PKA activator) and PKI (a PKA inhibitor). This was done to study the effects of PM<sub>2.5</sub> on the cAMP-PKA pathway, which is involved in respiratory mucosal cilia beating, thereby elucidating the mechanisms involved.</p>
</sec>
<sec sec-type="methods" id="sec2">
<title>Methods</title>
<sec id="sec3">
<title>Collection and characterization analysis of PM<sub>2.5</sub> sample</title>
<p>The collection and extraction of PM<sub>2.5</sub> had been conducted in our previous study (<xref ref-type="bibr" rid="ref27">27</xref>). In summary, PM<sub>2.5</sub> was collected through a quartz fiber filter (8&#x202F;&#x00D7;&#x202F;10 in, Pall, USA) with an airborne particulate sampler (TH-1000CII, Wuhan Tianhong, China) at a flow rate of 10<sup>5</sup> m<sup>3</sup>/min for 24&#x202F;h. The fine particles were extracted from the filter using ultrasonication and then concentrated through vacuum freeze-drying. The obtained product was weighed and stored at a temperature of &#x2212;20&#x00B0;C. The PM<sub>2.5</sub> was resuspended in deionized water to reach the requisite concentrations for the experiment and stored at 4&#x00B0;C. Simultaneously, the PM<sub>2.5</sub> resuspension was monitored using a transmission electron microscope (TEM) (JEOL JEM2100, Japan) to examine the morphology of PM<sub>2.5</sub>.</p>
</sec>
<sec id="sec4">
<title>Extraction and preparation of airway axonemes</title>
<p>The isolation of bovine respiratory ciliary axonemes had been conducted using a method previously described (<xref ref-type="bibr" rid="ref28">28</xref>). Initially, fresh bovine bronchial tracts were collected from a local abattoir and rinsed twice with phosphate-buffered saline (PBS) before the removal of excess fat and connective tissue. Subsequently, 15&#x202F;mL of extraction buffer, comprising 1&#x202F;mM EDTA, 20&#x202F;mM Tris&#x2013;HCl, 10&#x202F;mM calcium chloride, 50&#x202F;mM NaCl, 1&#x202F;mM dithiothreitol, 100&#x202F;mM Triton X-100, and7 mM 2-mercaptoethanol, was added. Large hemostats were then used to close both the proximal and distal ends of the trachea. Following vigorous oscillation of the trachea in both upward and downward directions for 90&#x202F;s, the extraction buffer with the released axonemal proteins was passed through a 100&#x202F;&#x03BC;m polypropylene mesh. The prepared sample was subsequently centrifuged at 17,250 g for 7&#x202F;min, after which the supernatant was discarded and the axonemal protein pellet was resuspended in a resuspension buffer at a concentration of 1&#x202F;mg/mL. The resuspension buffer contained 50&#x202F;mM KCl, 20&#x202F;mM Tris HCL, 0.5&#x202F;mM EDTA, 4&#x202F;mM MgCl<sub>2</sub>, 10&#x202F;mM soybean trypsin inhibitor, 1&#x202F;mM dithiothreitol, and 25% sucrose (w/v). The isolated axonemes were stored at &#x2212;80&#x00B0;C in a refrigerator for 6&#x202F;months.</p>
</sec>
<sec id="sec5">
<title>Experimental treatment of airway axonemes</title>
<p>Frozen aliquots of axonemes were thawed on ice, kept at 4&#x00B0;C, and gently aspirated with a pipette to minimize aggregation for subsequent use. A sonicator (Branson 2,510, Branson Ultrasonics, United States) was used to prepare PM<sub>2.5</sub> suspensions by treating for 5&#x202F;min at 160&#x202F;W and 20&#x202F;kHz. The PM<sub>2.5</sub> suspensions were then diluted to five concentrations (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL). To activate or inhibit the airway axonemes, corresponding concentrations of 10&#x202F;&#x03BC;M cAMP and 2&#x202F;&#x03BC;g/mL PKI were added, respectively. Finally, axoneme samples were added and diluted to a final concentration of 0.25&#x2013;0.5&#x202F;mg/mL. The mixtures were then incubated in microcentrifuge tubes at room temperature for 10&#x202F;min or 1&#x202F;h. At each time point measured, 10&#x202F;&#x03BC;L drop was removed from the sample microcentrifuge tube and placed into one well of a 48-well polystyrene tissue culture plate, breaking the meniscus of the drop so that the sample was evenly distributed. Axonemes maintained in a medium without PM<sub>2.5</sub> served as the control. Each experimental group comprised five replicate wells.</p>
</sec>
<sec id="sec6">
<title>Measurement of CBF</title>
<p>The CBF of isolated axonemes was determined using the SAVA system to quantify the impact of PM<sub>2.5</sub> on ciliary beating. Axonemes were fixed by centrifugation to prevent movement, and the majority of axonemes exhibited flexure in each field of view. As previously described, the experiments were conducted with temperature control using a thermostatic stage, maintained at 23&#x00B0;C&#x202F;&#x00B1;&#x202F;0.5&#x00B0;C. Motility was recorded for 10&#x202F;min at a sampling rate of 85 frames per second, for all experimental groups. Axonemes exhibiting a frequency of &#x2264; 2&#x202F;Hz were deemed nonmotile and thus excluded from the analysis. Similarly, data points exhibiting a frequency of less than 10% of the original number of beats were excluded from the analysis. For each experimental condition, at least six separate fields were captured, analyzed, and expressed as the mean &#x00B1; standard deviation per data point.</p>
</sec>
<sec id="sec7">
<title>Statistical analysis</title>
<p>A minimum of three separate experiments were performed for each unique parameter. The experimental data were analyzed using GraphPad Prism 9.0 software and are presented as mean &#x00B1; S.D. For data comparisons involving three or more groups used one-way analysis of variance (one-way ANOVA) with Dunnett&#x2019;s test, and Student&#x2019;s t-test was used for comparisons between two groups. <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 was considered to be statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="sec8">
<title>Results</title>
<sec id="sec9">
<title>Characterization analysis of PM<sub>2.5</sub> samples</title>
<p>The morphological characteristics of PM<sub>2.5</sub> were observed and photographed using TEM. As shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, after the fine particulate matter sample, preserved by freeze-drying, was resuspended in deionized water. PM<sub>2.5</sub> particles displayed a range of sizes and shapes, both as individual particles (monomers) and as aggregates, predominantly consisting of irregular fine and ultrafine particles.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Upon observation with transmission electron microscopy, it was discovered that PM<sub>2.5</sub> consists of particles with irregular shapes, which are either dispersed individually or aggregated into clusters.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g001.tif"/>
</fig>
</sec>
<sec id="sec10">
<title>PM<sub>2.5</sub> affected the CBF of ciliary axonemes</title>
<p>In order to evaluate the possible toxic effects of PM<sub>2.5</sub> on ciliary axonemes, the changes in CBF were determined after treating the axonemes with various PM<sub>2.5</sub> concentrations (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) for 10&#x202F;min, respectively. Results in <xref ref-type="fig" rid="fig2">Figure 2A</xref> showed the change of CBF after 10&#x202F;min of treating with different concentrations of PM<sub>2.5</sub>. <xref ref-type="fig" rid="fig2">Figure 2B</xref> showed the average value of CBF over a 10-min period. In the control group, the average CBF was 3.75&#x202F;&#x00B1;&#x202F;0.10&#x202F;Hz. With the concentrations of PM<sub>2.5</sub> increased, the average CBF reached the highest at 12.5&#x202F;&#x03BC;g/mL, which was 4.09&#x202F;&#x00B1;&#x202F;0.08&#x202F;Hz and approximately 10% higher than the control group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). Nevertheless, when the concentration was up to 100&#x202F;&#x03BC;g/mL, the CBF of ciliary axonemes decreased to 3.49&#x202F;&#x00B1;&#x202F;0.09&#x202F;Hz, representing a decrease of about 6.9% compared to the control group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). The results suggested that exposure to low concentrations (6.25, 12.5, 25&#x202F;&#x03BC;g/mL) of PM<sub>2.5</sub> might promote the frequency of axoneme beating and that a decrease in CBF might occur when the axonemes were exposed to high-concentration PM<sub>2.5</sub>.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>The CBF was detected after the ciliary axonemes were exposed to varying concentrations of PM<sub>2.5</sub> (6.25, 12.5, 25, 50, 100&#x202F;&#x03BC;g/mL) for 10&#x202F;min. Ciliary axons exposed to 10&#x202F;&#x03BC;M cAMP was set as positive control. <bold>(A)</bold> Ciliary axons were exposed to different concentrations of PM<sub>2.5</sub> for 10&#x202F;min. Given the necessity for system stabilization, CBF was monitored from 2&#x202F;min onwards at 30s intervals. <bold>(B)</bold> The averages of CBF at different concentrations of PM<sub>2.5</sub>. The findings indicated that axonemes increased CBF when treated with low concentrations of PM<sub>2.5</sub>, particularly at 12.5 and 25&#x202F;&#x03BC;g/mL PM<sub>2.5</sub> concentrations, and ciliary beating was inhibited at high concentration (100&#x202F;&#x03BC;g/mL). The data were expressed as mean &#x00B1; S.D. of three independent experiments. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05&#x202F;PM<sub>2.5</sub>-treated group compared with the control group.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g002.tif"/>
</fig>
</sec>
<sec id="sec11">
<title>The effect of PKA inhibitor on the axonemes exposed to PM<sub>2.5</sub></title>
<p>Previous studies demonstrated that the stimulation of PKA resulted in the phosphorylation of downstream target proteins, thereby stimulating CBF. Concurrently, PKA played a dual role in ciliary muscle regulation, as it potently activated ciliary muscle pulsation by releasing Ca<sup>2+</sup> from intracellular stores and moderately prolonged CBF through a Ca<sup>2+</sup>-independent mechanism (<xref ref-type="bibr" rid="ref29">29</xref>). Protein kinase inhibitor peptide (PKI) was an endogenous thermostable peptide that effectively and specifically inhibited the activity of the free catalytic subunit of cAMP-dependent protein kinase (<xref ref-type="bibr" rid="ref30">30</xref>). To further investigate whether PKA mediates PM<sub>2.5</sub>-induced CBF alterations, the PKA inhibiter PKI was introduced to this study. If PKI effectively inhibits PM<sub>2.5</sub>-induced ciliary CBF elevation, this would indicate that PKA activation plays a critical role in PM<sub>2.5</sub>-mediated ciliary motility increases. Thus, the groups were set as: control group, control plus PKI-treated group, PM<sub>2.5</sub>-treated groups (12.5 or 25&#x202F;&#x03BC;g/mL), and PM<sub>2.5</sub> (12.5 or 25&#x202F;&#x03BC;g/mL) plus PKI-treated groups. The PM<sub>2.5</sub> plus PKI-treated group showed a significant decrease compared with the PM<sub>2.5</sub>-treated group (<xref ref-type="fig" rid="fig3">Figure 3</xref>). At a PM<sub>2.5</sub> concentration of 12.5&#x202F;&#x03BC;g/mL, the mean CBF was 4.12&#x202F;&#x00B1;&#x202F;0.12&#x202F;Hz. However, the CBF of the PM<sub>2.5</sub> concentration of 12.5&#x202F;&#x03BC;g/mL plus PKI group was 2.46&#x202F;&#x00B1;&#x202F;0.03&#x202F;Hz, which was approximately 1.71 times lower than that of the PM<sub>2.5</sub>-treated group. Moreover, the CBF in both PM<sub>2.5</sub>-treated groups was found to be significantly different from that of the control group. However, no difference was observed between the PM<sub>2.5</sub> plus PKI-treated groups and the control plus PKI-treated group. These results suggested that PKI could effectively inhibit PM<sub>2.5</sub>-induced changes in CBF. Thus, PM<sub>2.5</sub> might affect the CBF of ciliary axons by modulating the activity of PKA.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>The effect of PKI on the axonemes exposed to PM<sub>2.5</sub>. The results indicated that the PKA inhibitor (PKI) significantly inhibited PM<sub>2.5</sub>-treated CBF. All experiments were repeated three times. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, PM<sub>2.5</sub>-treated group compared with corresponding PM<sub>2.5</sub> plus PKI group. #<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, PM<sub>2.5</sub>-treated group without PKI compared with the control group.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g003.tif"/>
</fig>
</sec>
<sec id="sec12">
<title>The effect of cAMP on the axonemes exposed to PM<sub>2.5</sub></title>
<p>PKA, the protein kinase of cAMP, could be specifically activated by cAMP. Furthermore, it had been demonstrated that increases in CBF were associated with cAMP activation. To determine whether the increase in CBF stimulated by PM<sub>2.5</sub> was related to the activation of cAMP, extracted axonemes were exposed to varying concentrations of PM<sub>2.5</sub> (6.25, 12.5, 25 and 50&#x202F;&#x03BC;g/mL) for 10&#x202F;min, followed by incubation in the presence or absence of 10&#x202F;&#x03BC;M cAMP, and then measured the CBF. The experimental groups were set up as follows: a control group, a control plus cAMP-treated group, PM<sub>2.5</sub>-treated (6.25, 12.5, 25, and 50&#x202F;&#x03BC;g/mL) group, and PM<sub>2.5</sub> (6.25, 12.5, 25, and 50&#x202F;&#x03BC;g/mL) plus cAMP-treated group. As illustrated in <xref ref-type="fig" rid="fig4">Figure 4</xref>, the PM<sub>2.5</sub> plus cAMP-treated group exhibited significantly higher CBF than the PM<sub>2.5</sub>-treated group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). This result suggested that cAMP could markedly enhance the activity of ciliary axons under PM<sub>2.5</sub> treatment. Moreover, at PM<sub>2.5</sub> concentration of up to 50&#x202F;&#x03BC;g/mL, a significant downward trend in CBF was observed compared to the control plus cAMP-treated group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). The results suggested that high concentrations of PM<sub>2.5</sub> might reduce PM<sub>2.5</sub>-induced axonal beating by affecting the activation of cAMP, thereby inhibiting PKA activity.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>The effect of cAMP on the axonemes exposed to PM<sub>2.5</sub>. These results indicated that cAMP significantly boosted ciliary axon activity when exposed to PM<sub>2.5</sub>. In addition, the 50&#x202F;&#x03BC;g/mL PM<sub>2.5</sub> plus cAMP-treated group resulted in significantly lower CBF compared to the 25&#x202F;&#x03BC;g/mL PM<sub>2.5</sub> plus cAMP-treated group. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05&#x202F;PM<sub>2.5</sub> plus cAMP-treated group compared to PM<sub>2.5</sub>-treated group. &#x2020;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05&#x202F;PM<sub>2.5</sub> plus cAMP-treated group compared to the control plus cAMP treated group. #<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05&#x202F;PM<sub>2.5</sub>-treated group compared to the control group.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g004.tif"/>
</fig>
</sec>
<sec id="sec13">
<title>The effect of long-term PM<sub>2.5</sub> exposure on ciliary axoneme activity</title>
<p>The above study demonstrated that PM<sub>2.5</sub> has a dual effect on CBF. Short-term exposure simulations of 10&#x202F;min revealed a significant increase in CBF at low PM<sub>2.5</sub> concentrations, contrasted with a marked decrease in CBF at higher concentrations. 50&#x202F;&#x03BC;g/mL PM<sub>2.5</sub> was found to significantly suppress CBF in ciliary axonemes. To further verify the changes in axonemes following prolonged exposure to PM<sub>2.5</sub>, extracted axonemes were treated with different concentrations of PM<sub>2.5</sub> (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) for 1&#x202F;h, and the changes in CBF were measured every 30&#x202F;s during the last 10&#x202F;min of the stimulation. The experimental groups were as set as: control group, PM<sub>2.5</sub>-treated (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) group. As illustrated in <xref ref-type="fig" rid="fig5">Figure 5</xref>, the mean CBF in all concentration groups of the PM<sub>2.5</sub>-treated (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) group was lower than that of the control group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). Furthermore, even low concentrations of PM<sub>2.5</sub> (12.5, 25&#x202F;&#x03BC;g/mL) did not produce the same level of activation when stimulating axonemes as that observed in the previously simulated short-term exposure. These results suggested that long-term exposure to PM<sub>2.5</sub> might result in a reduction in the activity of ciliary axonemes and a decrease in the beat frequency.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The CBF was detected after the ciliary axonemes had been exposed to different concentrations of PM<sub>2.5</sub> (6.25, 12.5, 25, 50, 100&#x202F;&#x03BC;g/mL) for 1&#x202F;h. The CBF exhibited a decline over time in the context of prolonged PM<sub>2.5</sub> stimulation. The prolonged exposure of the ciliary axonemes to PM<sub>2.5</sub> resulted in a lower CBF in the PM<sub>2.5</sub>-exposed group than in the control group. Data were presented as mean &#x00B1; S.D. of three independent experiments performed in triplicate. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, PM<sub>2.5</sub> treated group compared to the control group.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g005.tif"/>
</fig>
</sec>
<sec id="sec14">
<title>The effect of cAMP on axonemes long-term exposed to PM<sub>2.5</sub></title>
<p>The aforementioned findings demonstrated that 1-h exposure to PM<sub>2.5</sub> resulted in a decline in CBF. To further investigate the effect of long-term exposure to PM<sub>2.5</sub> on the CBF of ciliary axonemes activated by cAMP, the extracted axonemes were treated with PM<sub>2.5</sub> at concentrations of 6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL for 1&#x202F;h. At the last 10&#x202F;min of the 1-h treatment, 10&#x202F;&#x03BC;M cAMP was added, and CBF was measured every 30&#x202F;s. Ciliary axonemes treated with cAMP alone (no PM<sub>2.5</sub> exposure) were designated as the control group. The experimental groups were set as: control group, PM<sub>2.5</sub> (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) plus cAMP-treated group. As shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, the mean of CBF in the PM<sub>2.5</sub> (6.25, 12.5, 25, 50, and 100&#x202F;&#x03BC;g/mL) plus cAMP-treated group was markedly lower than that of the control group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). The findings demonstrated that, although the addition of cAMP activated the axonemes, Long-term exposure to PM<sub>2.5</sub> impaired the ability of airway epithelial axonemes to exhibit cAMP-stimulated increases in CBF.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Exposure to PM<sub>2.5</sub> for 1&#x202F;h desensitized axonemes to cAMP stimulation. The results showed that under long-term exposure to PM<sub>2.5</sub> at concentrations of 12.5&#x202F;&#x03BC;g/mL and above, cAMP was unable to activate CBF to the same level as the control group. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, PM<sub>2.5</sub>-treated group compared with control group.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<title>Discussion</title>
<p>Air pollution has consistently been a global concern for human health, with numerous studies demonstrating that exposure to air pollution increased the incidence of lung diseases and mortality rates (<xref ref-type="bibr" rid="ref31 ref32 ref33">31&#x2013;33</xref>), particularly PM<sub>2.5</sub> in the air (<xref ref-type="bibr" rid="ref34">34</xref>). PM<sub>2.5</sub> has been recognized as a major air pollutant posing serious public health risks. The World Health Organization (WHO) in their 2021 publication of the WHO Global Air Quality Guidelines revealed a reduction in the annual mean concentration of PM<sub>2.5</sub> in the air quality guidelines (AQG level) from 10&#x202F;&#x03BC;g/m<sup>3</sup> in 2005 to 5&#x202F;&#x03BC;g/m<sup>3</sup>. Even at lower exposure levels, PM<sub>2.5</sub> could have adverse effects on health. Mucociliary clearance acts as the primary line of defense mechanism of the host respiratory tract, with ciliary beating representing a significant factor in its functionality. In this study, we explored the mechanism of PM<sub>2.5</sub> on airway ciliary axon beating, which contributed to further understanding of PM<sub>2.5</sub>-induced respiratory diseases.</p>
<p>Firstly, we investigated the impact of varying concentrations of PM<sub>2.5</sub> on axonal motility to elucidate the effects of PM<sub>2.5</sub> on axonal CBF and the underlying mechanism. Initially, we measured the CBF of ciliary axonemes exposed to different concentrations of PM<sub>2.5</sub> for 10&#x202F;min. The findings indicated that CBF increased at low PM<sub>2.5</sub> concentrations but decreased at high concentrations (<xref ref-type="fig" rid="fig2">Figure 2</xref>). At PM<sub>2.5</sub> concentrations of 12.5, and 25&#x202F;&#x03BC;g/mL, ciliary activity was significantly higher than that of the control group; however, when the dose was increased to 100&#x202F;&#x03BC;g/mL, CBF was apparently lower than that of the control group. As known, after foreign compounds enter the respiratory tract, they adhere to the cilia of airway epithelial cells, which regularly beat to clear inhaled substances and produce mucus, a process known as MCC system. MCC serves as the primary innate defense mechanism in the lungs, with the normal functioning of cilia being essential for effective MCC. The frequency and amplitude of ciliary beating governed the velocity of MCC (<xref ref-type="bibr" rid="ref35">35</xref>). Nevertheless, the potential impact of PM<sub>2.5</sub> on the ciliary activity of airway epithelial cells has not been well described. Our results revealed that after exposure to low concentrations of PM<sub>2.5</sub>, ciliary axonemes immediately increased the CBF of airway epithelium. To minimize the mechanical damage of PM<sub>2.5</sub> to airway epithelium, the body promptly activated the MCC, clearing invasive particles from the airway as quickly as possible and accelerating particle transport to the airway, thereby increasing CBF (<xref ref-type="bibr" rid="ref36">36</xref>). It is reasonable to suggest that airway epithelial cells have the ability to immediately promote ciliary activity upon PM<sub>2.5</sub> inhalation, which accelerates the initial host defense of clearing particles from the airway. Additionally, the study has shown that in mucus-free murine and human airway epithelia, cilia increased their beat frequency to maintain particle transport (<xref ref-type="bibr" rid="ref37">37</xref>). However, when the PM<sub>2.5</sub> concentration reached 100&#x202F;&#x03BC;g/mL, the beating frequency of ciliary axonemes decreased significantly, indicating that high concentration of PM<sub>2.5</sub> might induce axoneme damage, thereby reducing axonal motility. A study using a chronic rhinitis rabbit model found that PM<sub>2.5</sub> exposure severely damaged cilia and cilial structures, and even induced irreversible mucosal remodeling (<xref ref-type="bibr" rid="ref21">21</xref>). As a component of MCC, cilium axonemes constitute the body&#x2019;s first line of defense against PM<sub>2.5</sub>. When the concentration of PM<sub>2.5</sub> became too high, the axonemes might succumb to damage, reducing their ability to beat effectively.</p>
<p>The mechanism by which PM<sub>2.5</sub> regulated CBF was further investigated in the following study. The most common mechanisms known to increase CBF included calcium-dependent NO/cGMP-dependent phosphorylation, cAMP-dependent phosphorylation, and Ca<sup>2+</sup> action (<xref ref-type="bibr" rid="ref38">38</xref>). PKA, composed of two regulatory subunits and two catalytic subunits, undergoes dissociation upon binding of cAMP to its regulatory subunits, releasing the catalytic subunits to phosphorylate downstream substrates (<xref ref-type="bibr" rid="ref39">39</xref>). Numerous studies have evidenced the pivotal function of the cAMP-PKA signaling pathway in the maintenance of cellular homeostasis and oxidative metabolism. Therefore, to explore whether PM<sub>2.5</sub> affected CBF through the cAMP-PKA pathway, we introduced PKA activators (cAMP) and PKA inhibitors (PKI) in this study. The results shown in <xref ref-type="fig" rid="fig3">Figures 3</xref>, <xref ref-type="fig" rid="fig4">4</xref> demonstrated that PKI effectively inhibited the stimulatory effect of low-concentration PM<sub>2.5</sub> on CBF and that PM<sub>2.5</sub> significantly reduced the activity of cAMP-treated axonemes. The above results indicated that the cAMP-PKA pathway indeed participated in the PM<sub>2.5</sub>-induced changes in CBF. Additionally, it was reported that an increase in calcium ion concentration activated calcium-sensitive adenylate cyclase (tmAC), catalyzing the conversion of ATP to cAMP, resulting in increased cAMP production and ultimately leading to an increase in CBF, enhancing the ability of airway epithelial cells to clear mucus and foreign particles (<xref ref-type="bibr" rid="ref40">40</xref>). The intracellular cAMP level appeared to be an important determinant of the transport function of pulmonary mucociliary clearance (<xref ref-type="bibr" rid="ref41">41</xref>). In summary, cAMP signaling enhanced ciliary activity, thereby accelerating MCC, and the cAMP-PKA signaling pathway played a key role in initiating the host defense response in airway epithelial cells. Overall, our findings revealed that PM<sub>2.5</sub> affected the activity of airway epithelial cilia by acting on the cAMP-PKA signaling pathway.</p>
<p>In addition to the changes in PM<sub>2.5</sub> concentrations affecting toxic effects, exposure time was also identified as a crucial influencing factor. Therefore, in this study, we sought to simulate the long-term, low-dose PM<sub>2.5</sub> exposure that humans experience in their living environment, and to measure the impact of different concentrations of PM<sub>2.5</sub> exposure for 1&#x202F;h on ciliary activity. The results indicated that, unlike previous short-term exposure studies, in the extended period, CBF was significantly decreased in all PM<sub>2.5</sub>-exposed groups compared to the control group (<xref ref-type="fig" rid="fig5">Figure 5</xref>). This suggested that long-term PM<sub>2.5</sub> exposure significantly inhibited ciliary activity, raising the question of whether there was potential damage to the structure and function of the cilia. Previous research has shown that the beating of respiratory epithelial cilia was a vital component of the mucociliary transport apparatus (<xref ref-type="bibr" rid="ref42 ref43 ref44">42&#x2013;44</xref>). Structurally, cilia are microtubule-based organelles that extend from the basal body, which is a centriole located at the cell apex and contains the axoneme. The axoneme is the microtubule cytoskeleton of the cilium, comprising nine doublet microtubules encircling a central pair (9&#x202F;+&#x202F;2). Each doublet microtubule has an inward-directed dynein arm and an outward-directed dynein arm, which generate the force required for movement in an ATP-dependent process (<xref ref-type="bibr" rid="ref45">45</xref>). Changes in CBF depend on the outer dynein arms, hence, defects in the outer dynein arms are associated with decreased CBF (<xref ref-type="bibr" rid="ref46 ref47 ref48 ref49 ref50">46&#x2013;50</xref>). Additionally, studies have found that exposure to silica particles could cause abnormal ultrastructure of respiratory cilia, including central microtubule absence, microtubule disarray, and axoneme loss, as well as a notable reduction in the number of ciliary axonemes and basal bodies in the ciliated epithelium, with the proportion of abnormal axonemes increasing with exposure concentration (<xref ref-type="bibr" rid="ref51">51</xref>). Therefore, the decrease in CBF under long-term PM<sub>2.5</sub> exposure might have been due to structural damage to the ciliary axonemes by PM<sub>2.5</sub>, particularly to the outer dynein arms. Additionally, we tested the effect of adding cAMP to see if it could counteract the decrease in CBF caused by prolonged PM<sub>2.5</sub> exposure. The findings demonstrated that, even with the addition of cAMP, different concentrations of PM<sub>2.5</sub> exposure still resulted in CBF levels below the control group (<xref ref-type="fig" rid="fig6">Figure 6</xref>). This suggested that long-term PM<sub>2.5</sub> exposure downregulated the cAMP-PKA pathway involved in axoneme beating. Previous studies have shown that the phosphorylation level of PKA in rat hippocampal neurons was significantly inhibited after prolonged PM<sub>2.5</sub> exposure (<xref ref-type="bibr" rid="ref52">52</xref>). However, the specific potential mechanisms by which PM<sub>2.5</sub> inhibited the cAMP-PKA pathway required further investigation. The results of the impact of long-term PM<sub>2.5</sub> exposure on CBF demonstrated that prolonged exposure to PM<sub>2.5</sub> led to a significant decrease in CBF, potentially due to structural damage and downregulation of the cAMP-PKA pathway, highlighting the need for further research into the underlying mechanisms.</p>
</sec>
<sec sec-type="conclusions" id="sec16">
<title>Conclusion</title>
<p>The present study focused on early changes in ciliary activity under different concentrations and durations of PM<sub>2.5</sub> exposure. Our data provided new findings that inhaled PM<sub>2.5</sub> stimulated ciliary activity through the cAMP-PKA signaling pathway, and that short-term stimulation at low concentrations increased ciliary CBF, whereas high concentrations and prolonged exposure to PM<sub>2.5</sub> reduced ciliary activity. This might be an important mechanism by which PM<sub>2.5</sub> affected the airways from responding to both normal and pathological stimuli, and it was closely related to the development of lung diseases. The entire article is sorted out in <xref ref-type="fig" rid="fig7">Figure 7</xref>.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Schematic illustration of the effect of PM2.5 exposure on CBF in airway cilia. PM2.5 regulated ciliary activity via the cAMP-PKA signaling pathway, where short-term and low-concentration stimulation increased CBF, whereas long-term and high-concentration exposure reduced it.</p>
</caption>
<graphic xlink:href="fpubh-13-1529215-g007.tif"/>
</fig>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec17">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="sec18">
<title>Author contributions</title>
<p>JP: Data curation, Formal analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ZX: Conceptualization, Formal analysis, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. KZ: Methodology, Supervision, Writing &#x2013; review &#x0026; editing. YL: Conceptualization, Formal analysis, Project administration, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec19">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<ack>
<p>The authors wish to acknowledge Dr. Wyatt, Dr. DeVasure, and Dr. Price from the Department of Environmental, Agricultural, and Occupational Health, University of Nebraska Medical Center for their invaluable guidance and assistance during the experimental process.</p>
</ack>
<sec sec-type="COI-statement" id="sec20">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec21">
<title>Generative AI statement</title>
<p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec22">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">World Health Organization</collab></person-group> (<year>2024</year>). <source>Who to host second global conference on air pollution and health</source>. Available at: <ext-link xlink:href="https://www.who.int/news-room/events/detail/2025/03/25/default-calendar/second-global-conference-on-air-pollution-and-health" ext-link-type="uri">https://www.who.int/news-room/events/detail/2025/03/25/default-calendar/second-global-conference-on-air-pollution-and-health</ext-link></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><collab id="coll2">GBD 2021 Risk factors collaborators 2024</collab></person-group>. <article-title>Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021</article-title>. <source>Lancet</source>. (<year>2021</year>) <volume>403</volume>:<fpage>2162</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00933-4</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>D</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name> <name><surname>He</surname> <given-names>F</given-names></name></person-group>. <article-title>Exploring Pm2.5 environmental efficiency and its influencing factors in China</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>18</volume>:<fpage>12218</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph182212218</pub-id>, PMID: <pub-id pub-id-type="pmid">34831974</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Liang</surname> <given-names>S</given-names></name> <name><surname>Du</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Sun</surname> <given-names>B</given-names></name> <name><surname>Zhao</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Pm(2.5) aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells</article-title>. <source>Environ Pollut</source>. (<year>2019</year>) <volume>249</volume>:<fpage>482</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envpol.2019.03.045</pub-id>, PMID: <pub-id pub-id-type="pmid">30928520</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>S</given-names></name></person-group>. <article-title>The effects and pathogenesis of Pm2.5 and its components on chronic obstructive pulmonary disease</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>. (<year>2023</year>) <volume>18</volume>:<fpage>493</fpage>&#x2013;<lpage>506</lpage>. doi: <pub-id pub-id-type="doi">10.2147/COPD.S402122</pub-id>, PMID: <pub-id pub-id-type="pmid">37056681</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>EM</given-names></name> <name><surname>Chao</surname> <given-names>CC</given-names></name> <name><surname>Wang</surname> <given-names>MT</given-names></name> <name><surname>Hsu</surname> <given-names>CL</given-names></name> <name><surname>Chen</surname> <given-names>PC</given-names></name></person-group>. <article-title>Pm(2.5) promotes pulmonary fibrosis by mitochondrial dysfunction</article-title>. <source>Environ Toxicol</source>. (<year>2023</year>) <volume>38</volume>:<fpage>1905</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1002/tox.23817</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Yin</surname> <given-names>X</given-names></name> <name><surname>Zheng</surname> <given-names>X</given-names></name></person-group>. <article-title>The relationship between Pm2.5 and the onset and exacerbation of childhood asthma: a short communication</article-title>. <source>Front Pediatr</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1191852</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fped.2023.1191852</pub-id>, PMID: <pub-id pub-id-type="pmid">37593445</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parida</surname> <given-names>T</given-names></name> <name><surname>Daka</surname> <given-names>G</given-names></name> <name><surname>Murapala</surname> <given-names>D</given-names></name> <name><surname>Kolli</surname> <given-names>SK</given-names></name> <name><surname>Malla</surname> <given-names>RR</given-names></name> <name><surname>Namuduri</surname> <given-names>S</given-names></name></person-group>. <article-title>Pm2.5: epigenetic alteration in lung physiology and lung Cancer pathogenesis</article-title>. <source>Crit Rev Oncog</source>. (<year>2023</year>) <volume>28</volume>:<fpage>51</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1615/CritRevOncog.2023049651</pub-id>, PMID: <pub-id pub-id-type="pmid">38050981</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname> <given-names>A</given-names></name> <name><surname>Salath&#x00E9;</surname> <given-names>M</given-names></name> <name><surname>O'riordan</surname> <given-names>TG</given-names></name></person-group>. <article-title>Mucociliary clearance in the airways</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>1996</year>) <volume>154</volume>:<fpage>1868</fpage>&#x2013;<lpage>902</lpage>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm.154.6.8970383</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedaghat</surname> <given-names>MH</given-names></name> <name><surname>Shahmardan</surname> <given-names>MM</given-names></name> <name><surname>Norouzi</surname> <given-names>M</given-names></name> <name><surname>Heydari</surname> <given-names>M</given-names></name></person-group>. <article-title>Effect of cilia beat frequency on Muco-ciliary clearance</article-title>. <source>J Biomed Phys Eng</source>. (<year>2016</year>) <volume>6</volume>:<fpage>265</fpage>&#x2013;<lpage>78</lpage>.</citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tratnjek</surname> <given-names>L</given-names></name> <name><surname>Kreft</surname> <given-names>M</given-names></name> <name><surname>Kristan</surname> <given-names>K</given-names></name> <name><surname>Kreft</surname> <given-names>ME</given-names></name></person-group>. <article-title>Ciliary beat frequency of in vitro human nasal epithelium measured with the simple high-speed microscopy is applicable for safety studies of nasal drug formulations</article-title>. <source>Toxicol in Vitro</source>. (<year>2020</year>) <volume>66</volume>:<fpage>104865</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tiv.2020.104865</pub-id>, PMID: <pub-id pub-id-type="pmid">32311434</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munkholm</surname> <given-names>M</given-names></name> <name><surname>Mortensen</surname> <given-names>J</given-names></name></person-group>. <article-title>Mucociliary clearance: pathophysiological aspects</article-title>. <source>Clin Physiol Funct Imaging</source>. (<year>2014</year>) <volume>34</volume>:<fpage>171</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cpf.12085</pub-id>, PMID: <pub-id pub-id-type="pmid">24119105</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikolaizik</surname> <given-names>W</given-names></name> <name><surname>Hahn</surname> <given-names>J</given-names></name> <name><surname>Bauck</surname> <given-names>M</given-names></name> <name><surname>Weber</surname> <given-names>S</given-names></name></person-group>. <article-title>Comparison of ciliary beat frequencies at different temperatures in young adults</article-title>. <source>Erj Open Res</source>. (<year>2020</year>) <volume>6</volume>:<fpage>00477</fpage>&#x2013;<lpage>2020</lpage>. doi: <pub-id pub-id-type="doi">10.1183/23120541.00477-2020</pub-id>, PMID: <pub-id pub-id-type="pmid">33263055</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakahari</surname> <given-names>T</given-names></name> <name><surname>Suzuki</surname> <given-names>C</given-names></name> <name><surname>Kawaguchi</surname> <given-names>K</given-names></name> <name><surname>Hosogi</surname> <given-names>S</given-names></name> <name><surname>Tanaka</surname> <given-names>S</given-names></name> <name><surname>Asano</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Ambroxol-enhanced frequency and amplitude of beating cilia controlled by a voltage-gated ca(2+) channel, Cav1.2, via pH(i) increase and [cl(&#x2212;)](i) decrease in the lung airway epithelial cells of mice</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<fpage>16976</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms242316976</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>LF</given-names></name> <name><surname>White</surname> <given-names>DR</given-names></name> <name><surname>Andreoli</surname> <given-names>SM</given-names></name> <name><surname>Mulligan</surname> <given-names>RM</given-names></name> <name><surname>Discolo</surname> <given-names>CM</given-names></name> <name><surname>Schlosser</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Cigarette smoke inhibits dynamic ciliary beat frequency in pediatric adenoid explants</article-title>. <source>Otolaryngol Head Neck Surg</source>. (<year>2012</year>) <volume>146</volume>:<fpage>659</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0194599811431414</pub-id>, PMID: <pub-id pub-id-type="pmid">22237301</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>F</given-names></name> <name><surname>Pavlik</surname> <given-names>J</given-names></name> <name><surname>Fox</surname> <given-names>L</given-names></name> <name><surname>Scarbrough</surname> <given-names>C</given-names></name> <name><surname>Sale</surname> <given-names>WS</given-names></name> <name><surname>Sisson</surname> <given-names>JH</given-names></name> <etal/></person-group>. <article-title>Alcohol-induced ciliary dysfunction targets the outer dynein arm</article-title>. <source>Am J Phys Lung Cell Mol Phys</source>. (<year>2015</year>) <volume>308</volume>:<fpage>L569</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.00257.2014</pub-id>, PMID: <pub-id pub-id-type="pmid">25595647</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mickenhagen</surname> <given-names>A</given-names></name> <name><surname>Siefer</surname> <given-names>O</given-names></name> <name><surname>Neugebauer</surname> <given-names>P</given-names></name> <name><surname>Stennert</surname> <given-names>E</given-names></name></person-group>. <article-title>The influence of different alpha-sympathomimetic drugs and benzalkoniumchlorid on the ciliary beat frequency of in vitro cultured human nasal mucosa cells</article-title>. <source>Laryngorhinootologie</source>. (<year>2008</year>) <volume>87</volume>:<fpage>30</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-2007-966891</pub-id>, PMID: <pub-id pub-id-type="pmid">17879181</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inui</surname> <given-names>TA</given-names></name> <name><surname>Yasuda</surname> <given-names>M</given-names></name> <name><surname>Hirano</surname> <given-names>S</given-names></name> <name><surname>Ikeuchi</surname> <given-names>Y</given-names></name> <name><surname>Kogiso</surname> <given-names>H</given-names></name> <name><surname>Inui</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Enhancement of ciliary beat amplitude by carbocisteine in ciliated human nasal epithelial cells</article-title>. <source>Laryngoscope</source>. (<year>2020</year>) <volume>130</volume>:<fpage>E289</fpage>&#x2013;<lpage>e297</lpage>. doi: <pub-id pub-id-type="doi">10.1002/lary.28185</pub-id>, PMID: <pub-id pub-id-type="pmid">31294840</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Fan</surname> <given-names>W</given-names></name> <name><surname>Wu</surname> <given-names>H</given-names></name> <name><surname>Yao</surname> <given-names>Y</given-names></name> <name><surname>Jin</surname> <given-names>L</given-names></name> <name><surname>Chen</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Naringenin attenuated airway cilia structural and functional injury induced by cigarette smoke extract via Il-17 and camp pathways</article-title>. <source>Phytomedicine</source>. (<year>2024</year>) <volume>126</volume>:<fpage>155053</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2023.155053</pub-id>, PMID: <pub-id pub-id-type="pmid">38359483</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katsumata</surname> <given-names>M</given-names></name> <name><surname>Fujisawa</surname> <given-names>T</given-names></name> <name><surname>Kamiya</surname> <given-names>Y</given-names></name> <name><surname>Tanaka</surname> <given-names>Y</given-names></name> <name><surname>Kamiya</surname> <given-names>C</given-names></name> <name><surname>Inoue</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium</article-title>. <source>BMC Pulm Med</source>. (<year>2022</year>) <volume>22</volume>:<fpage>186</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-022-01983-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35527239</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>R</given-names></name> <name><surname>Guo</surname> <given-names>Z</given-names></name> <name><surname>Dong</surname> <given-names>W</given-names></name> <name><surname>Deng</surname> <given-names>C</given-names></name> <name><surname>Han</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Effects of Pm2.5 on mucus secretion and tissue remodeling in a rabbit model of chronic rhinosinusitis</article-title>. <source>Int Forum Allergy Rhinol</source>. (<year>2018</year>) <volume>8</volume>:<fpage>1349</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alr.22182</pub-id>, PMID: <pub-id pub-id-type="pmid">29999600</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salathe</surname> <given-names>M</given-names></name></person-group>. <article-title>Regulation of mammalian ciliary beating</article-title>. <source>Annu Rev Physiol</source>. (<year>2007</year>) <volume>69</volume>:<fpage>401</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.040705.141253</pub-id>, PMID: <pub-id pub-id-type="pmid">16945069</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname> <given-names>TA</given-names></name> <name><surname>Forg&#x00E8;t</surname> <given-names>MA</given-names></name> <name><surname>Adams</surname> <given-names>JM</given-names></name> <name><surname>Sisson</surname> <given-names>JH</given-names></name></person-group>. <article-title>Both camp and cgmp are required for maximal ciliary beat stimulation in a cell-free model of bovine ciliary axonemes</article-title>. <source>Am J Phys Lung Cell Mol Phys</source>. (<year>2005</year>) <volume>288</volume>:<fpage>L546</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.00107.2004</pub-id>, PMID: <pub-id pub-id-type="pmid">15542545</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>JH</given-names></name> <name><surname>Choi</surname> <given-names>HJ</given-names></name> <name><surname>Kang</surname> <given-names>YJ</given-names></name> <name><surname>Kim</surname> <given-names>YS</given-names></name> <name><surname>Lee</surname> <given-names>SY</given-names></name> <name><surname>Kwon</surname> <given-names>RJ</given-names></name> <etal/></person-group>. <article-title>Mhy4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the Pka-camp-response element-binding protein pathway in squamous cell lung cancer</article-title>. <source>Exp Hematol Oncol</source>. (<year>2022</year>) <volume>11</volume>:<fpage>68</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40164-022-00324-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36209131</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>WB</given-names></name> <name><surname>Li</surname> <given-names>JT</given-names></name> <name><surname>Hui</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>XY</given-names></name> <name><surname>Yan</surname> <given-names>SG</given-names></name></person-group>. <article-title>Combination of pseudoephedrine and emodin ameliorates Lps-induced acute lung injury by regulating macrophage M1/M2 polarization through the Vip/camp/Pka pathway</article-title>. <source>Chin Med</source>. (<year>2022</year>) <volume>17</volume>:<fpage>19</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13020-021-00562-8</pub-id>, PMID: <pub-id pub-id-type="pmid">35123524</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jcik-Pszczo&#x0142;a</surname> <given-names>K</given-names></name> <name><surname>Ch&#x0142;o&#x0144;-Rzepa</surname> <given-names>G</given-names></name> <name><surname>Jankowska</surname> <given-names>A</given-names></name> <name><surname>&#x015A;lusarczyk</surname> <given-names>M</given-names></name> <name><surname>Ferdek</surname> <given-names>PE</given-names></name> <name><surname>Kusiak</surname> <given-names>AA</given-names></name> <etal/></person-group>. <article-title>A novel, Pan-Pde inhibitor exerts anti-fibrotic effects in human lung fibroblasts via inhibition of Tgf-&#x03B2; signaling and activation of camp/Pka signaling</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<fpage>4008</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms21114008</pub-id>, PMID: <pub-id pub-id-type="pmid">32503342</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>S</given-names></name> <name><surname>Zhuang</surname> <given-names>G</given-names></name> <name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>Q</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Signal transductions of Beas-2B cells in response to carcinogenic pm(2.5) exposure based on a microfluidic system</article-title>. <source>Anal Chem</source>. (<year>2017</year>) <volume>89</volume>:<fpage>5413</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.analchem.7b00218</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sisson</surname> <given-names>JH</given-names></name> <name><surname>Pavlik</surname> <given-names>JA</given-names></name> <name><surname>Wyatt</surname> <given-names>TA</given-names></name></person-group>. <article-title>Alcohol stimulates ciliary motility of isolated airway axonemes through a nitric oxide, cyclase, and cyclic nucleotide-dependent kinase mechanism</article-title>. <source>Alcohol Clin Exp Res</source>. (<year>2009</year>) <volume>33</volume>:<fpage>610</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1530-0277.2008.00875.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19183138</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname> <given-names>TA</given-names></name> <name><surname>Spurzem</surname> <given-names>JR</given-names></name> <name><surname>May</surname> <given-names>K</given-names></name> <name><surname>Sisson</surname> <given-names>JH</given-names></name></person-group>. <article-title>Regulation of ciliary beat frequency by both Pka and Pkg in bovine airway epithelial cells</article-title>. <source>Am J Phys</source>. (<year>1998</year>) <volume>275</volume>:<fpage>L827</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.1998.275.4.L827</pub-id>, PMID: <pub-id pub-id-type="pmid">9755116</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname> <given-names>GD</given-names></name> <name><surname>Dewey</surname> <given-names>WL</given-names></name></person-group>. <article-title>Protein kinase inhibitor peptide (Pki): a family of endogenous neuropeptides that modulate neuronal camp-dependent protein kinase function</article-title>. <source>Neuropeptides</source>. (<year>2006</year>) <volume>40</volume>:<fpage>23</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.npep.2005.10.002</pub-id>, PMID: <pub-id pub-id-type="pmid">16442618</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jerrett</surname> <given-names>M</given-names></name></person-group>. <article-title>Air pollution as a risk for death from infectious respiratory disease</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2022</year>) <volume>205</volume>:<fpage>1374</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.202202-0351ED</pub-id>, PMID: <pub-id pub-id-type="pmid">35353654</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>L</given-names></name> <name><surname>Cai</surname> <given-names>M</given-names></name> <name><surname>Tian</surname> <given-names>F</given-names></name> <name><surname>Zou</surname> <given-names>H</given-names></name> <name><surname>Qian</surname> <given-names>ZM</given-names></name> <etal/></person-group>. <article-title>Air pollution associated with incidence and progression trajectory of chronic lung diseases: a population-based cohort study</article-title>. <source>Thorax</source>. (<year>2023</year>) <volume>78</volume>:<fpage>698</fpage>&#x2013;<lpage>705</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thorax-2022-219489</pub-id>, PMID: <pub-id pub-id-type="pmid">36732083</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zhao</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Air pollution: a culprit of lung cancer</article-title>. <source>J Hazard Mater</source>. (<year>2022</year>) <volume>434</volume>:<fpage>128937</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhazmat.2022.128937</pub-id>, PMID: <pub-id pub-id-type="pmid">35452993</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C</given-names></name> <name><surname>Cai</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>R</given-names></name> <name><surname>Sera</surname> <given-names>F</given-names></name> <name><surname>Guo</surname> <given-names>Y</given-names></name> <name><surname>Tong</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Coarse particulate air pollution and daily mortality: a global study in 205 cities</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2022</year>) <volume>206</volume>:<fpage>999</fpage>&#x2013;<lpage>1007</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.202111-2657OC</pub-id>, PMID: <pub-id pub-id-type="pmid">35671471</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Bustamante-Marin</surname> <given-names>XM</given-names></name> <name><surname>Ostrowski</surname> <given-names>LE</given-names></name></person-group>. <source>Cilia and Mucociliary clearance.</source> <publisher-name>Cold Spring Harb Perspect Biol</publisher-name> (<year>2017</year>). <fpage>9</fpage>:<fpage>a028241</fpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a028241</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00F6;nig</surname> <given-names>P</given-names></name> <name><surname>Krain</surname> <given-names>B</given-names></name> <name><surname>Krasteva</surname> <given-names>G</given-names></name> <name><surname>Kummer</surname> <given-names>W</given-names></name></person-group>. <article-title>Serotonin increases cilia-driven particle transport via an acetylcholine-independent pathway in the mouse trachea</article-title>. <source>PLoS One</source>. (<year>2009</year>) <volume>4</volume>:<fpage>e4938</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0004938</pub-id>, PMID: <pub-id pub-id-type="pmid">19290057</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bermbach</surname> <given-names>S</given-names></name> <name><surname>Weinhold</surname> <given-names>K</given-names></name> <name><surname>Roeder</surname> <given-names>T</given-names></name> <name><surname>Petersen</surname> <given-names>F</given-names></name> <name><surname>Kugler</surname> <given-names>C</given-names></name> <name><surname>Goldmann</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Mechanisms of cilia-driven transport in the airways in the absence of mucus</article-title>. <source>Am J Respir Cell Mol Biol</source>. (<year>2014</year>) <volume>51</volume>:<fpage>56</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1165/rcmb.2012-0530OC</pub-id>, PMID: <pub-id pub-id-type="pmid">24467665</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lieb</surname> <given-names>T</given-names></name> <name><surname>Frei</surname> <given-names>CW</given-names></name> <name><surname>Frohock</surname> <given-names>JI</given-names></name> <name><surname>Bookman</surname> <given-names>RJ</given-names></name> <name><surname>Salathe</surname> <given-names>M</given-names></name></person-group>. <article-title>Prolonged increase in ciliary beat frequency after short-term purinergic stimulation in human airway epithelial cells</article-title>. <source>J Physiol</source>. (<year>2002</year>) <volume>538</volume>:<fpage>633</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2001.013222</pub-id>, PMID: <pub-id pub-id-type="pmid">11790825</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ould Amer</surname> <given-names>Y</given-names></name> <name><surname>Hebert-Chatelain</surname> <given-names>E</given-names></name></person-group>. <article-title>Mitochondrial camp-Pka signaling: what do we really know?</article-title> <source>Biochim Biophys Acta Bioenerg</source>. (<year>2018</year>) <volume>1859</volume>:<fpage>868</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbabio.2018.04.005</pub-id>, PMID: <pub-id pub-id-type="pmid">29694829</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nlend</surname> <given-names>MC</given-names></name> <name><surname>Schmid</surname> <given-names>A</given-names></name> <name><surname>Sutto</surname> <given-names>Z</given-names></name> <name><surname>Ransford</surname> <given-names>GA</given-names></name> <name><surname>Conner</surname> <given-names>GE</given-names></name> <name><surname>Fregien</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Calcium-mediated, purinergic stimulation and polarized localization of calcium-sensitive adenylyl cyclase isoforms in human airway epithelia</article-title>. <source>FEBS Lett</source>. (<year>2007</year>) <volume>581</volume>:<fpage>3241</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.febslet.2007.06.015</pub-id>, PMID: <pub-id pub-id-type="pmid">17586501</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname> <given-names>A</given-names></name> <name><surname>Bai</surname> <given-names>G</given-names></name> <name><surname>Schmid</surname> <given-names>N</given-names></name> <name><surname>Zaccolo</surname> <given-names>M</given-names></name> <name><surname>Ostrowski</surname> <given-names>LE</given-names></name> <name><surname>Conner</surname> <given-names>GE</given-names></name> <etal/></person-group>. <article-title>Real-time analysis of camp-mediated regulation of ciliary motility in single primary human airway epithelial cells</article-title>. <source>J Cell Sci</source>. (<year>2006</year>) <volume>119</volume>:<fpage>4176</fpage>&#x2013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.03181</pub-id>, PMID: <pub-id pub-id-type="pmid">16984973</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braiman</surname> <given-names>A</given-names></name> <name><surname>Priel</surname> <given-names>Z</given-names></name></person-group>. <article-title>Efficient mucociliary transport relies on efficient regulation of ciliary beating</article-title>. <source>Respir Physiol Neurobiol</source>. (<year>2008</year>) <volume>163</volume>:<fpage>202</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.resp.2008.05.010</pub-id>, PMID: <pub-id pub-id-type="pmid">18586580</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutland</surname> <given-names>J</given-names></name> <name><surname>Griffin</surname> <given-names>WM</given-names></name> <name><surname>Cole</surname> <given-names>PJ</given-names></name></person-group>. <article-title>Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways</article-title>. <source>Am Rev Respir Dis</source>. (<year>1982</year>) <volume>125</volume>:<fpage>100</fpage>&#x2013;<lpage>5</lpage>.</citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yager</surname> <given-names>JA</given-names></name> <name><surname>Ellman</surname> <given-names>H</given-names></name> <name><surname>Dulfano</surname> <given-names>MJ</given-names></name></person-group>. <article-title>Human ciliary beat frequency at three levels of the tracheobronchial tree</article-title>. <source>Am Rev Respir Dis</source>. (<year>1980</year>) <volume>121</volume>:<fpage>661</fpage>&#x2013;<lpage>5</lpage>. PMID: <pub-id pub-id-type="pmid">7386979</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satir</surname> <given-names>P</given-names></name> <name><surname>Christensen</surname> <given-names>ST</given-names></name></person-group>. <article-title>Overview of structure and function of mammalian cilia</article-title>. <source>Annu Rev Physiol</source>. (<year>2007</year>) <volume>69</volume>:<fpage>377</fpage>&#x2013;<lpage>400</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.040705.141236</pub-id>, PMID: <pub-id pub-id-type="pmid">17009929</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chilvers</surname> <given-names>MA</given-names></name> <name><surname>Rutman</surname> <given-names>A</given-names></name> <name><surname>O'callaghan</surname> <given-names>C</given-names></name></person-group>. <article-title>Ciliary beat pattern is associated with specific ultrastructural defects in primary ciliary dyskinesia</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2003</year>) <volume>112</volume>:<fpage>518</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0091-6749(03)01799-8</pub-id>, PMID: <pub-id pub-id-type="pmid">13679810</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jorissen</surname> <given-names>M</given-names></name></person-group>. <article-title>Correlations among mucociliary transport, ciliary function, and ciliary structure</article-title>. <source>Am J Rhinol</source>. (<year>1998</year>) <volume>12</volume>:<fpage>53</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.2500/105065898782102945</pub-id>, PMID: <pub-id pub-id-type="pmid">9513660</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossman</surname> <given-names>CM</given-names></name> <name><surname>Forrest</surname> <given-names>JB</given-names></name> <name><surname>Lee</surname> <given-names>RM</given-names></name> <name><surname>Newhouse</surname> <given-names>AF</given-names></name> <name><surname>Newhouse</surname> <given-names>MT</given-names></name></person-group>. <article-title>The dyskinetic cilia syndrome; abnormal ciliary motility in association with abnormal ciliary ultrastructure</article-title>. <source>Chest</source>. (<year>1981</year>) <volume>80</volume>:<fpage>860</fpage>&#x2013;<lpage>5</lpage>.</citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stannard</surname> <given-names>W</given-names></name> <name><surname>O'callaghan</surname> <given-names>C</given-names></name></person-group>. <article-title>Ciliary function and the role of cilia in clearance</article-title>. <source>J Aerosol Med</source>. (<year>2006</year>) <volume>19</volume>:<fpage>110</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1089/jam.2006.19.110</pub-id>, PMID: <pub-id pub-id-type="pmid">16551222</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willems</surname> <given-names>T</given-names></name> <name><surname>Jorissen</surname> <given-names>M</given-names></name></person-group>. <article-title>Correlations between ciliary structure and ciliary function</article-title>. <source>Acta Otorhinolaryngol Belg</source>. (<year>2000</year>) <volume>54</volume>:<fpage>299</fpage>&#x2013;<lpage>308</lpage>.</citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Q</given-names></name> <name><surname>Fu</surname> <given-names>G</given-names></name> <name><surname>Lin</surname> <given-names>H</given-names></name> <name><surname>Zhao</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Influence of silica particles on mucociliary structure and Muc5B expression in airways of C57bl/6 mice</article-title>. <source>Exp Lung Res</source>. (<year>2020</year>) <volume>46</volume>:<fpage>217</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1080/01902148.2020.1762804</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Yuan</surname> <given-names>P</given-names></name> <name><surname>Cheng</surname> <given-names>L</given-names></name> <name><surname>Sun</surname> <given-names>H</given-names></name> <name><surname>Gui</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Role of Pka/Creb/Bdnf signaling in Pm2.5-induced neurodevelopmental damage to the hippocampal neurons of rats</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2021</year>) <volume>214</volume>:<fpage>112005</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ecoenv.2021.112005</pub-id>, PMID: <pub-id pub-id-type="pmid">33640725</pub-id></citation></ref>
</ref-list>
</back>
</article>